ANGPT2 and cancer: Results from studies with these and related molecules have been encouraging, with reports of Ang2 inhibitors promoting tumor regression and suppressing metastatic disease in cancer and decreasing leukocyte infiltration and vascular remodeling in airway inflammation (6, 9, 11, 12).